Head of Integrated BioBank of Luxembourg (IBBL) and Transversal Translational Medicine (TTM) operat.
The LIH is conducting patient centeredtranslational research in close collaboration with Luxembourg Hospitals andclinical centers in cross-border region. The goal is to realizebed-to-bench-to-bed translational cycles, that start with unmet patient needsand use data driven research with patient-based models to drive programs backinto clinical application. While the IBBL as an integrated Biobank is the centerpiece of LIHs translational effort, the translational medicine effort isincluding a number of additional platforms from clinical trial design, overquantitative biology units to screening platforms for patient based diseasemodels. The position is integrating the operational management of extendedtranslational research programs.
[Press Release] First Luxembourg patient enrolled in new European clinical trial against COVID-19
The first of a total of 60 patients from Luxembourg foreseen to take part in the European clinical trial “Discovery” was recruited today at the Centre Hospitalier de Luxembourg (CHL).
[Article series] The experts behind Luxembourg’s Covid-19 fight
Dr Manon Gantenbein is the current Director of the Clinical and Epidemiological Investigation Centre (CIEC) of the LIH Department of Population Health.
Spontaneous Internship applications
Are you interested in an internship at LIH or IBBL? feel free to send us your application including a cv and a cover letter . Don't forget to mention the department and the period of time that is of interest to you. Thank you !
[Press Release] A deconfinement strategy framed by health and research measures
As part of its exit strategy, the Luxembourg government can count on the support of Luxembourg research, namely the Research Luxembourg COVID-19 Task Force.
First PhD defence under CANBIO training programme
On Monday, April 27th, the first PhD defence under the CANBIO doctoral research and training programme took place at the premises of the University of Luxembourg in Belval.
[Press Release] Predicting the severity of COVID-19 infection
The Research Luxembourg COVID-19 task force announces the start of “Predi-COVID ”, a study that aims to identify important risk factors and biomarkers associated with COVID-19 severity and long-term health consequences of the disease in Luxembourg.
[Press Release] André Losch Fondation supports research on COVID-19 with a generous donation
André Losch Fondation announced its participation in the fight against the COVID-19 pandemic by supporting Research Luxembourg with one of its most significant donations yet. The foundation’s commitment of 1,4 million euros will help financing three COVID-19 studies currently underway in Luxembourg: the CON-VINCE study, aiming to evaluate the dynamics of the spread of the disease within Luxembourg; the Predi-COVID study, dedicated to finding predictive markers for disease severity; and a study that develops statistical projections and modelling of the epidemic. On top of this André Losch Fondation will also provide financing for four vans that will allow nurses to collect tissue samples of study participants, thereby sparing them a trip to the hospital.